Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young Hee Rho

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Seminars in Nephrology|October 18, 2011
The epidemiology of uric acid and fructoseYoung Hee Rho, Yanyan Zhu, Hyon K Choi
Advances in Therapy|August 3, 2019
Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid ArthritisYoung Hee Rho, Anna Rychlewska-Hańczewska, Beata Śliwowska, et al.
Annals of the Rheumatic Diseases|August 10, 2016
Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and AzevedoPaul Emery, Jiří Vencovský, Jeehoon Ghil, et al.
Rheumatology (Oxford, England)|August 14, 2012
Risk factors for pseudogout in the general populationYoung Hee Rho, Yanyan Zhu, Yuqing Zhang, et al.
The American Journal of Medicine|June 21, 2014
The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trialsTzeyu L Michaud, Young Hee Rho, Tatyana Shamliyan, et al.
Archives of Drug Information|February 17, 2010
Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk FactorsYoung Hee Rho, Annette Oeser, Cecilia P Chung, et al.
Archives of Drug Information|August 18, 2009
Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk FactorsYoung Hee Rho, Annette Oeser, Cecilia P Chung, et al.
Rheumatology International|May 10, 2003
The biallelic variable number of tandem repeats of the tumor necrosis factor receptor 2 promoter in systemic lupus erythematosusYoung Ho Lee, Young Hee Rho, Seong Jae Choi, et al.
Rheumatology International|January 17, 2007
The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptorYoung Hee Rho, Seong Jae Choi, Young Ho Lee, et al.
Rheumatology International|August 16, 2006
Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysisYoung Ho Lee, Young Hee Rho, Seong Jae Choi, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Seminars in Nephrology|October 18, 2011
The epidemiology of uric acid and fructoseYoung Hee Rho, Yanyan Zhu, Hyon K Choi
Advances in Therapy|August 3, 2019
Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid ArthritisYoung Hee Rho, Anna Rychlewska-Hańczewska, Beata Śliwowska, et al.
Annals of the Rheumatic Diseases|August 10, 2016
Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and AzevedoPaul Emery, Jiří Vencovský, Jeehoon Ghil, et al.
Rheumatology (Oxford, England)|August 14, 2012
Risk factors for pseudogout in the general populationYoung Hee Rho, Yanyan Zhu, Yuqing Zhang, et al.
The American Journal of Medicine|June 21, 2014
The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trialsTzeyu L Michaud, Young Hee Rho, Tatyana Shamliyan, et al.
Archives of Drug Information|February 17, 2010
Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk FactorsYoung Hee Rho, Annette Oeser, Cecilia P Chung, et al.
Archives of Drug Information|August 18, 2009
Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk FactorsYoung Hee Rho, Annette Oeser, Cecilia P Chung, et al.
Rheumatology International|May 10, 2003
The biallelic variable number of tandem repeats of the tumor necrosis factor receptor 2 promoter in systemic lupus erythematosusYoung Ho Lee, Young Hee Rho, Seong Jae Choi, et al.
Rheumatology International|January 17, 2007
The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptorYoung Hee Rho, Seong Jae Choi, Young Ho Lee, et al.
Rheumatology International|August 16, 2006
Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysisYoung Ho Lee, Young Hee Rho, Seong Jae Choi, et al.
Pageof 6